original ) (raw )Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost
George Cremona
Heart (British Cardiac Society), 1998
View PDFchevron_right
Iloprost—different indications and different national experiences in treating pulmonary hypertension
Dursun Alehan
Clinical Research in Cardiology Supplements, 2010
View PDFchevron_right
Transition from prostacyclin analogue infusion to oral therapy in patients with pulmonary arterial hypertension: a 5-year follow-up
Tahir Ahmed
Pulmonary circulation, 2013
View PDFchevron_right
Transition from Prostacyclin Analogue Infusion to Oral Therapy in Patients with Pulmonary Arterial Hypertension: A Five Year Follow-Up
Tahir Jameel
Journal of the American College of Cardiology, 2013
View PDFchevron_right
Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study
Serdar Küçükoğlu
The Anatolian Journal of Cardiology, 2021
View PDFchevron_right
Aerosolized Iloprost Therapy Could Not Replace Long-term IV Epoprostenol (Prostacyclin) Administration in Severe Pulmonary Hypertension*
Meinhard Kneussl
CHEST Journal, 2001
View PDFchevron_right
Prostacyclin and Iloprost in the Treatment of Primary Pulmonary Hypertension
Christopher McCabe
View PDFchevron_right
Long-term therapy with inhaled iloprost in patients with pulmonary hypertension
Heinrike Wilkens , Juergen Behr
Respiratory Medicine, 2010
View PDFchevron_right
Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue
Michael Hamm
New England Journal of Medicine, 2000
View PDFchevron_right
Long term inhalation of iloprost in a child with primary pulmonary hypertension: an alternative to continuous infusion
Peter Rimensberger
Heart, 2001
View PDFchevron_right
Assessment of the vasodilator response in primary pulmonary hypertension Comparing prostacyclin and iloprost administered by either infusion or inhalation
Michael Linscheid
European Heart Journal, 2003
View PDFchevron_right
Oral Prostacyclin Therapy for Pulmonary Arterial Hypertension : Another Step Forward
Aaron Waxman
View PDFchevron_right
Inhaled iloprost for therapy in pulmonary arterial hypertension
R. Ewert
Expert Review of Respiratory Medicine, 2011
View PDFchevron_right
Short- and Long-Term Effects of Inhaled Iloprost Therapy in Children With Pulmonary Arterial Hypertension
Daniela Brady , Donna Parker
Journal of the American College of Cardiology, 2008
View PDFchevron_right
The use of iloprost in the treatment of ‘out of proportion’ pulmonary hypertension in chronic obstructive pulmonary disease
Szymon Skoczyński , Bartosz Lasota
International Journal of Clinical Pharmacy, 2013
View PDFchevron_right
Prostacyclin Use Among Patients with Pulmonary Arterial Hypertension in the United States: A Retrospective Analysis of a Large Health Care Claims Database
Charles D Burger
Journal of managed care & specialty pharmacy, 2017
View PDFchevron_right
Adverse Events of Prostacyclin Mimetics in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
Mohammad Eddama
Journal of Clinical Medicine
View PDFchevron_right
The evolution of prostacyclins in pulmonary arterial hypertension: from classical treatment to modern management
Charles D Burger
The American journal of managed care, 2016
View PDFchevron_right
Long-term experience after transition from parenteral prostanoids to oral agents in patients with pulmonary hypertension
Gustavo Heresi
Respiratory Medicine, 2008
View PDFchevron_right
Long-term treatment of pulmonary hypertension with aerosolized iloprost
Meinhard Kneussl
The European respiratory journal, 2000
View PDFchevron_right
Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol)
W. Tomkowski
Annals of Internal …, 1990
View PDFchevron_right
Inhaled Iloprost for Severe Pulmonary Hypertension
Gerald Simonneau , Werner Seeger
New England Journal of Medicine, 2002
View PDFchevron_right
Inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension
Caio Julio César Santos Fernandes
Pulmonary Circulation
View PDFchevron_right
Prognostic Factors in Severe Pulmonary Hypertension Patients Who Need Parenteral Prostanoid Therapy: The Impact of Late Referral
Dario Vizza , Alfred Nona , Massimo Mancone , Carlo Iacoboni , Serena Marcon
CHEST Journal, 2011
View PDFchevron_right
Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertension
George Sokos , Amresh Raina
Pulmonary Circulation, 2013
View PDFchevron_right
Safety and Efficacy of Transition from Inhaled Treprostinil to Parenteral Treprostinil in Selected Patients with Pulmonary Arterial Hypertension
Jeremy Feldman
Pulmonary circulation, 2014
View PDFchevron_right
Long term treatment of pulmonary arterial hypertension with beraprost, an oral prostacyclin analogue
Sergio Morelli
Heart (British Cardiac Society), 2001
View PDFchevron_right
Impact of Parenteral Prostanoids in Pulmonary Arterial Hypertension: The Relevance of Timing
Michela Boromei
Journal of Clinical Medicine
View PDFchevron_right
Acute and long-term effects of inhaled iloprost in portopulmonary hypertension
Juan Gonzalez-Abraldes
Liver Transplantation, 2010
View PDFchevron_right
Treatment of a case of acute right heart failure by inhalation of iloprost, a long-acting prostacyclin analogue
Olaf Wendler
European Journal of Anaesthesiology, 2001
View PDFchevron_right
Long-term outcomes of domiciliary intravenous iloprost in idiopathic and connective tissue disease-associated pulmonary arterial hypertension
Nehal Hussain
Respirology, 2016
View PDFchevron_right
Saudi experience in the management of pulmonary arterial hypertension; The outcome of PAH therapy with the exclusion of chronic parenteral prostacyclin
Enas Batubara
Annals of Thoracic Medicine
View PDFchevron_right
Prostacyclin Administration Errors in Pulmonary Arterial Hypertension Patients Admitted to Hospitals in the United States: A National Survey
Fernando Torres
CHEST Journal, 2009
View PDFchevron_right